PDP
PDP
Skip to content Skip to navigation menu
Your browser is not supported by this site.
Please update to the latest version, or use a different browser for the best experience.
Guide to Biosimilars Litigation and Regulation in the U.S., 2019-2020 ed.

Author(s):

Product details:

Format: Book - softbound
Brand: Thomson West
Copyright: 2019
ISBN: 9781539286721
Service #: 42658211
Sub #: 42658210
Pages: 708
Shelf Space: 2 in.
Publication frequency: Updated as changes in the law dictate
Update method: No updating

Can we help?

Contact Us 
Call 1-888-728-7677
New Product

Guide to Biosimilars Litigation and Regulation in the U.S., 2019-2020 ed.

106616646

Availability:

In stock
(details)

106616646
106616646
One time purchase
$150.00
Purchase the current version only, no updates will be sent.


Guide to Biosimilars Litigation and Regulation in the U.S. is an understandable guide and go-to reference, providing expert and practical guidance for attorneys working in this burgeoning area of the law.

The title explores each section of the Biologics Price Competition and Innovation Act (BPCIA) as well as an overview of legal and regulatory issues unique to biosimilars that have arisen or are expected to arise in litigation concerning biosimilar products.

This resource also includes discussion of the 20+ cases making their way through the judicial system.

Related statutes and regulations, agency guidance, and other relevant materials are included in the extensive appendices.

Features

  • Includes applicable statutes and regulations
  • Provides relevant FDA guidance
  • Highlights areas for consideration during the FDA approval process
  • Gives practitioner guidance
  • Summarizes Biosimilars Price Competition and Innovation Act (BPCIA)
  • Analyzes current case law